Cadila Healthcare informs about press release

07 Jul 2018 Evaluate

Cadila Healthcare has informed about a press release dated July 07, 2018, titled ‘Zydus receives tentative approval from the USFDA for Deferasirox Tablets for Oral Suspension’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

963.50 15.60 (1.65%)
29-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.95
Dr. Reddys Lab 6279.95
Cipla 1407.55
Zydus Lifesciences 963.50
Lupin 1640.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.